155 related articles for article (PubMed ID: 36255281)
1. Impact of SARS-Cov-2 infection in patients with hypertrophic cardiomyopathy: results of an international multicentre registry.
Gimeno JR; Olivotto I; Rodríguez AI; Ho CY; Fernández A; Quiroga A; Espinosa MA; Gómez-González C; Robledo M; Tojal-Sierra L; Day SM; Owens A; Barriales-Villa R; Larrañaga JM; Rodríguez-Palomares J; González-Del-Hoyo M; Piqueras-Flores J; Reza N; Chumakova O; Ashley EA; Parikh V; Wheeler M; Jacoby D; Pereira AC; Saberi S; Helms AS; Villacorta E; Gallego-Delgado M; de Castro D; Domínguez F; Ripoll-Vera T; Zorio-Grima E; Sánchez-Martínez JC; García-Álvarez A; Arbelo E; Mogollón MV; Fuentes-Cañamero ME; Grande E; Peña C; Monserrat L; Lakdawala NK;
ESC Heart Fail; 2022 Aug; 9(4):2189-2198. PubMed ID: 36255281
[TBL] [Abstract][Full Text] [Related]
2. Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry.
Marstrand P; Han L; Day SM; Olivotto I; Ashley EA; Michels M; Pereira AC; Wittekind SG; Helms A; Saberi S; Jacoby D; Ware JS; Colan SD; Semsarian C; Ingles J; Lakdawala NK; Ho CY;
Circulation; 2020 Apr; 141(17):1371-1383. PubMed ID: 32228044
[TBL] [Abstract][Full Text] [Related]
3. Patients' Characteristics and Clinical Course of Hypertrophic Cardiomyopathy in a Regional Japanese Cohort - Results From Kochi RYOMA Study.
Kubo T; Hirota T; Baba Y; Ochi Y; Takahashi A; Yamasaki N; Hamashige N; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
Circ J; 2018 Feb; 82(3):824-830. PubMed ID: 29332907
[TBL] [Abstract][Full Text] [Related]
4. Association of Obesity With Adverse Long-term Outcomes in Hypertrophic Cardiomyopathy.
Fumagalli C; Maurizi N; Day SM; Ashley EA; Michels M; Colan SD; Jacoby D; Marchionni N; Vincent-Tompkins J; Ho CY; Olivotto I;
JAMA Cardiol; 2020 Jan; 5(1):65-72. PubMed ID: 31693057
[TBL] [Abstract][Full Text] [Related]
5. Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
Abou Alaiwi S; Roston TM; Marstrand P; Claggett BL; Parikh VN; Helms AS; Ingles J; Lampert R; Lakdawala NK; Michels M; Owens AT; Rossano JW; Saberi S; Abrams DJ; Ashley EA; Semsarian C; Stendahl JC; Ware JS; Miller E; Ryan TD; Russell MW; Day SM; Olivotto I; Vissing CR; Ho CY
Circulation; 2023 Aug; 148(5):394-404. PubMed ID: 37226762
[TBL] [Abstract][Full Text] [Related]
6. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy.
Lu DY; Pozios I; Haileselassie B; Ventoulis I; Liu H; Sorensen LL; Canepa M; Phillip S; Abraham MR; Abraham TP
J Am Heart Assoc; 2018 Feb; 7(5):. PubMed ID: 29478967
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
[TBL] [Abstract][Full Text] [Related]
8. Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe).
Ho CY; Day SM; Ashley EA; Michels M; Pereira AC; Jacoby D; Cirino AL; Fox JC; Lakdawala NK; Ware JS; Caleshu CA; Helms AS; Colan SD; Girolami F; Cecchi F; Seidman CE; Sajeev G; Signorovitch J; Green EM; Olivotto I
Circulation; 2018 Oct; 138(14):1387-1398. PubMed ID: 30297972
[TBL] [Abstract][Full Text] [Related]
9. Modes of death and clinical outcomes in adult patients with hypertrophic cardiomyopathy in Thailand.
Songsirisuk N; Kittipibul V; Methachittiphan N; Charoenattasil V; Zungsontiporn N; Spanuchart I; Buppajarntham S; Mankongpaisarnrung C; Satitthummanid S; Srimahachota S; Chattranukulchai P; Boonyaratavej Songmuang S; Puwanant S
BMC Cardiovasc Disord; 2019 Jan; 19(1):1. PubMed ID: 30606129
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, characteristics, and natural history of apical phenotype in a large cohort of patients with hypertrophic cardiomyopathy.
Rouskas P; Zegkos T; Ntelios D; Gossios T; Parcharidou D; Papanastasiou CA; Karamitsos T; Vassilikos V; Kouskouras K; Efthimiadis GK
Hellenic J Cardiol; 2023; 73():8-15. PubMed ID: 36775018
[TBL] [Abstract][Full Text] [Related]
11. Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; de Groot NM; van Domburg RT; Ten Cate FJ; Michels M
Clin Cardiol; 2014 Aug; 37(8):493-8. PubMed ID: 25044226
[TBL] [Abstract][Full Text] [Related]
12. Clinical features of the dilated phase of hypertrophic cardiomyopathy in comparison with those of dilated cardiomyopathy.
Hamada T; Kubo T; Kitaoka H; Hirota T; Hoshikawa E; Hayato K; Shimizu Y; Okawa M; Yamasaki N; Matsumura Y; Yabe T; Takata J; Doi YL
Clin Cardiol; 2010 Jul; 33(7):E24-8. PubMed ID: 20641106
[TBL] [Abstract][Full Text] [Related]
13. Predictors of future onset of atrial fibrillation in hypertrophic cardiomyopathy.
Cochet H; Morlon L; Vergé MP; Salel M; Camaioni C; Reynaud A; Peyrou J; Ritter P; Jais P; Laurent F; Lafitte S; Montaudon M; Réant P
Arch Cardiovasc Dis; 2018 Oct; 111(10):591-600. PubMed ID: 29884599
[TBL] [Abstract][Full Text] [Related]
14. Long-term results of dual-chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence for progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy.
Fananapazir L; Epstein ND; Curiel RV; Panza JA; Tripodi D; McAreavey D
Circulation; 1994 Dec; 90(6):2731-42. PubMed ID: 7994815
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical response to exercise in asymptomatic hypertrophic cardiomyopathy: a new description of outflow tract obstruction dynamics.
Lafitte S; Reant P; Touche C; Pillois X; Dijos M; Arsac F; Peyrou J; Montaudon M; Ritter P; Roudaut R; Demaria A
J Am Coll Cardiol; 2013 Aug; 62(9):842-50. PubMed ID: 23810875
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy.
Marston NA; Han L; Olivotto I; Day SM; Ashley EA; Michels M; Pereira AC; Ingles J; Semsarian C; Jacoby D; Colan SD; Rossano JW; Wittekind SG; Ware JS; Saberi S; Helms AS; Ho CY
Eur Heart J; 2021 May; 42(20):1988-1996. PubMed ID: 33769460
[TBL] [Abstract][Full Text] [Related]
17. Hypertrophic cardiomyopathies requiring more monitoring for less atrial fibrillation-related complications: a clustering analysis based on the French registry on hypertrophic cardiomyopathy (REMY).
Hourqueig M; Bouzille G; Mirabel M; Huttin O; Damy T; Labombarda F; Eicher JC; Charron P; Habib G; Réant P; Hagège A; Donal E;
Clin Res Cardiol; 2022 Feb; 111(2):163-174. PubMed ID: 34043053
[TBL] [Abstract][Full Text] [Related]
18. Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic Cardiomyopathy.
Eberly LA; Day SM; Ashley EA; Jacoby DL; Jefferies JL; Colan SD; Rossano JW; Semsarian C; Pereira AC; Olivotto I; Ingles J; Seidman CE; Channaoui N; Cirino AL; Han L; Ho CY; Lakdawala NK
JAMA Cardiol; 2020 Jan; 5(1):83-91. PubMed ID: 31799990
[TBL] [Abstract][Full Text] [Related]
19. Obstructive sleep apnea and hypertrophic cardiomyopathy: a common and potential harmful combination.
Nerbass FB; Pedrosa RP; Danzi-Soares NJ; Drager LF; Arteaga-Fernández E; Lorenzi-Filho G
Sleep Med Rev; 2013 Jun; 17(3):201-6. PubMed ID: 23046848
[TBL] [Abstract][Full Text] [Related]
20. Clinical characteristics and outcomes of dilated phase of hypertrophic cardiomyopathy: report from the registry data in Japan.
Goto D; Kinugawa S; Hamaguchi S; Sakakibara M; Tsuchihashi-Makaya M; Yokota T; Yamada S; Yokoshiki H; Tsutsui H;
J Cardiol; 2013 Jan; 61(1):65-70. PubMed ID: 23078864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
